Magro F, Fernandes S, Patita M, Arroja B, et al. The influence of subclinical active inflammation on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients. J Crohns Colitis 2024 Jan 19:jjae014. doi: 10.1093.
PMID: 38243908